BCDA

0.78501.60%
JM

Jay M. Moyes

Lead Independent Director

Mr. Jay M. Moyes, MBA, serves as Lead Independent Director of Sintx Technologies, Inc. from April, 2025. He was the Chief Financial Officer at Sera Prognostics, Inc. since March 2020 until June 2023. He served as the Chief Financial Officer of Amedica Corporation from October 2013 to August 7, 2014 and served as its Principal Accounting Officer until August 7, 2014. Mr. Moyes served as Chief Financial Officer of CareDx, Inc (alternative name XDx, Inc.) since May 2008 until July 2009. Mr. Moyes was the Chief Financial Officer and Treasurer of Myriad Genetics Inc. from June 1996 to November 1, 2007 and served as its Principal Accounting Officer and Assistant Secretary until November 1, 2007. He has been instrumental in the financial development and expansion of some of the medical industry's most groundbreaking companies including Myriad Genetics. He served as a Vice President of Finance at Myriad Genetics Inc. from July 1993 to July 2005. He served as the Vice President for Finance and Chief Financial Officer of Genmark Inc. from 1991 to July 1993. He served various positions with the accounting firm of KPMG LLP as a Senior Manager from 1979 to 1991. Mr. Moyes worked with numerous industry-leading companies through their transformation from emerging growth to established, publicly-traded companies. He had been Independent Director of Predictive Technology Group, Inc. since February 28, 2019 until December 2019. He served as a Member of the Board of Directors of Osiris Therapeutics, Inc. from May 2006 to December 2017. He had been Independent Director at Achieve Life Sciences, Inc. since August 1, 2017. He has been Independent Director at Puma Biotechnology, Inc. since April 27, 2012. He serves as Lead Independent Director of Puma Biotechnology, Inc. He served as an Independent Director of Integrated Diagnostics Incorporated since March 9, 2011 until 2016. He has been an Independent Director of BioCardia, Inc since January 2011. He served as a Director of OncoGenex Pharmaceuticals, Inc since August 1, 2017. Mr. Moyes served as a Trustee of the Utah Life Science Industry Association from 1999 to 2006. He served as a Director of Amedica Corporation from November 5, 2012 to August 7, 2014. He has an M.B.A. degree from the University of Utah, a B.A. degree in Economics from Weber State University and was formerly a Certified Public Accountant. (AICPA).

Positions